Is ProShares Ultra Nasdaq Biotechnology (BIB) a Buy, Sell, or Hold?
NASDAQ : BIB
ProShares Ultra Nasdaq Biotechnology — Competitors
$110.19 USD
$1.64 (1.51%)
- Volume
- 3.36K
- Average Volume
- 10.61K
- Market Capitalization
- $89.26M
- P/E Ratio
- Dividend Yield
- %
- Price Target
- Year High
- $110.29
- Year Low
- $52.71
- Day High
- —
- Day Low
- —
- Payout Ratio
- Current Ratio
BIB vs. The Competition
| Properties | BIB | BKSE | CAMX | DIVL |
|---|---|---|---|---|
| Market Cap | $89.26M | $89.56M | $66.96M | $60.88M |
| Shares Outstanding | $810.03K | $1.98M | $1.87M | $2.38M |
| P/E Ratio | ||||
| EPS | ||||
| Day Low | 108.83 | 45.22 | 35.73 | 25.505 |
| Day High | 110.29 | 45.41 | 35.73 | 25.6 |
| Year Low | 52.71 | 34.45334 | 29.885 | 22.121 |
| Year High | 110.29 | 46.02334 | 36.02 | 25.62 |
| Average Price 50 | 95.1158 | 43.93704 | 34.80322 | 24.85122 |
| Average Price 200 | 84.5726 | 40.30813 | 33.02928 | 24.23854 |
| Volume | 3357.34 | 1481 | 315 | 133 |
| Average Volume | - | - | - | - |